A Model of Care Based on Electronic Patient-Reported Outcomes for the Early Detection and Management of Immune-Related Adverse Events in Patients Under Immunotherapy: A Multicentric Phase II Randomized Controlled Trial (IePRO).
Prof. Dr. rer. Med. Manuela Eicher and Prof. Dr. med. Olivier Michielin have been awarded this “allocated fund for nursing research”, derived from a private donation, starting in November 2018.